Olema Pharmaceuticals, Inc. (OLMA)
14.87
-0.03
(-0.20%)
USD |
NASDAQ |
May 11, 16:00
14.87
0.00 (0.00%)
After-Hours: 19:41
Olema Pharmaceuticals Shareholders Equity (Quarterly) : 478.56M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | 319.94M |
| Protagonist Therapeutics, Inc. | 655.47M |
| Disc Medicine, Inc. | 688.43M |
| Nuvalent, Inc. | 1.174B |
| Aura Biosciences, Inc. | 136.91M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 677.32M |
| Total Liabilities (Quarterly) | 198.76M |
| Debt to Equity Ratio | 0.0088 |
| Current Ratio | 9.950 |
| Net Debt Paydown Yield | -0.02% |